TMED — EGF Theramed Health Balance Sheet
0.000.00%
- CA$1.51m
- CA$1.60m
- 12
- 15
- 56
- 17
Annual balance sheet for EGF Theramed Health, fiscal year end - June 30th, CAD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 0.364 | 0.703 | 0.015 | 0.012 | 0.01 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.124 | 0.139 | 0.155 | 0.17 | 0.201 |
Prepaid Expenses | |||||
Total Current Assets | 0.507 | 0.849 | 0.176 | 0.191 | 0.211 |
Net Property, Plant And Equipment | 0 | — | — | — | — |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 0.51 | 1.2 | 0.179 | 0.194 | 0.214 |
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2.55 | 2.41 | 2.51 | 2.67 | 2.92 |
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Liabilities | 1.01 | 1.11 | 1.2 | 1.34 | 1.55 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -0.504 | 0.091 | -1.02 | -1.14 | -1.34 |
Total Liabilities & Shareholders' Equity | 0.51 | 1.2 | 0.179 | 0.194 | 0.214 |
Total Common Shares Outstanding |